More proof that India is the new headwaters of generic drug-making: Watson Pharmaceuticals got the FDA to sign off on its production facility in Goa, India.
The California-based company didn't say which product or products it plans to make there, but did project that, by early 2008, it will be on pace to turn out 1 billion tablets and capsules there annually--all for sale on the U.S. market.

- check out the release [1] on the new facility 
- here's more [2] from Forbes

Related Articles:
China now leads India in ongoing clinical trials. Report [3]
Generic competition slashes prices. Report [4]
India's biotech future is bright. Report [5]